| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jeong Hun Hah | Q61199925 |
| P2093 | author name string | J Kanagalingam | |
| T A Le | |||
| J-C Lin | |||
| H Labib | |||
| R Feliciano | |||
| P2860 | cites work | Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment | Q74569553 |
| Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy | Q77054763 | ||
| Is povidone-iodine a hemostyptic? A clinical study | Q79732418 | ||
| Flurbiprofen: new indication. Lozenges: NSAIDs are not to be taken like sweets! | Q79833355 | ||
| Oral hygiene reduces respiratory infections in elderly bed-bound nursing home patients | Q80577569 | ||
| Can we prevent influenza-like illnesses by gargling? | Q81317954 | ||
| Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma | Q82845227 | ||
| Antifungal activity of three mouth rinses--in vitro study | Q83942218 | ||
| Ambroxol lozenges: new drug. Sore throat: better to just suck on hard candy | Q84194236 | ||
| Povidone-iodine: an anti-oedematous agent? | Q85246151 | ||
| Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 | ||
| Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia | Q24200442 | ||
| Antiseptics and disinfectants: activity, action, and resistance | Q24550729 | ||
| The global burden of oral diseases and risks to oral health | Q24649014 | ||
| Systematic review of the association between respiratory diseases and oral health | Q28261106 | ||
| Systematic review on the effect of rinsing with povidone-iodine during nonsurgical periodontal therapy | Q30883513 | ||
| Cancer treatment-induced oral mucositis. | Q33283032 | ||
| Cost-effectiveness of gargling for the prevention of upper respiratory tract infections | Q33393454 | ||
| Patient presentation and physician management of upper respiratory tract infections: a retrospective review of over 5 million primary clinic consultations in Hong Kong | Q33646392 | ||
| Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? | Q34026155 | ||
| Oral management of patients following oncology treatment: literature review | Q34048643 | ||
| Defining the normal bacterial flora of the oral cavity | Q34143846 | ||
| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. | Q34180792 | ||
| Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America | Q34298846 | ||
| Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis | Q34316358 | ||
| Selective adherence as a determinant of the host tropisms of certain indigenous and pathogenic bacteria | Q34385780 | ||
| Antibiotic resistance-the need for global solutions | Q34386251 | ||
| Prevention of upper respiratory tract infections by gargling: a randomized trial | Q34461843 | ||
| The inflammophilic character of the periodontitis-associated microbiota | Q34514076 | ||
| Management of chemotherapy-induced stomatitis. | Q34567582 | ||
| Selection of antimicrobial agents in periodontal therapy | Q34941942 | ||
| Management of upper respiratory tract infections in children | Q34994841 | ||
| The role of iodine in antisepsis and wound management: a reappraisal | Q35197592 | ||
| Guidelines for infection control in dental health-care settings--2003. | Q35611328 | ||
| Prevention of hospital-acquired pneumonia (strategies for prevention of hospital-acquired infections). | Q35678078 | ||
| Prevention of dental diseases following radiotherapy and chemotherapy | Q36002530 | ||
| Transmission of periodontal bacteria and models of infection | Q36243385 | ||
| Oral biofilms, periodontitis, and pulmonary infections | Q36481768 | ||
| Management of oral mucositis in patients who have cancer | Q36494114 | ||
| Clinical application of povidone-iodine oral antiseptic 1% (Betadine mouthwash) and povidone-iodine skin antiseptic 10% (Betadine solution) for the management of odontogenic and deep fascial space infection | Q46954527 | ||
| Professional oral care reduces influenza infection in elderly | Q47680726 | ||
| Oral problems and the dentist's role in the management of paediatric oncology patients | Q52873893 | ||
| Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. | Q53829938 | ||
| Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. | Q54572973 | ||
| Effects of Betaisodona on parameters of host defense. | Q54572977 | ||
| Drug resistance studies with topical antiseptics | Q54579110 | ||
| Antibacterial activity of povidone–iodine against an artificial biofilm of Porphyromonas gingivalis and Fusobacterium nucleatum | Q57919874 | ||
| Effect of Mouth Rinsing With Two Polyvinylpyrrolidone-Iodine Mixtures on Iodine Absorption and Thyroid Function* | Q58004835 | ||
| The burdens of cancer therapy | Q63446618 | ||
| Inactivation of human viruses by povidone-iodine in comparison with other antiseptics | Q64382562 | ||
| New aspects of mechanism of action of povidone-iodine | Q69862373 | ||
| Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies | Q70045686 | ||
| [Testing of mucosa disinfection methods in the mouth and throat. 1. Effect of chlorhexidine gluconate and PVP-iodine on alpha-hemolytic streptococci] | Q70748194 | ||
| Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care | Q72063532 | ||
| Reduction of viable bacteria in dental aerosols by preprocedural rinsing with an antiseptic mouthrinse | Q72606383 | ||
| Efficacy of common antiseptics against mycobacteria | Q73918069 | ||
| Nondevelopment of resistance by bacteria during hospital use of povidone-iodine | Q73950669 | ||
| Investigation on the efficacy of povidone-iodine against antiseptic-resistant species | Q73950673 | ||
| The effect of 1% povidone iodine as a pre-procedural mouthrinse in 20 patients with varying degrees of oral hygiene | Q74170296 | ||
| The role of basic oral care and good clinical practice principles in the management of oral mucositis | Q36507331 | ||
| The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review | Q36687474 | ||
| Oral mucositis: review of pathogenesis, diagnosis, prevention, and management | Q36903556 | ||
| Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. | Q37337761 | ||
| From randomized controlled trials to observational studies | Q37382509 | ||
| The oral microbiota: living with a permanent guest. | Q37402000 | ||
| Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature | Q37715768 | ||
| Antimicrobial effectiveness of povidone-iodine and consequences for new application areas | Q37871949 | ||
| The oral microbiome in health and disease and the potential impact on personalized dental medicine | Q37929297 | ||
| Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients | Q38119857 | ||
| Systematic review of basic oral care for the management of oral mucositis in cancer patients | Q38135744 | ||
| A comparison of the irritant and allergenic properties of antiseptics | Q38184822 | ||
| An unusual complication of late onset allergic contact dermatitis to povidone iodine in oral & maxillofacial surgery - a report of 2 cases | Q38232996 | ||
| Bacterial adhesion to oral tissues: a model for infectious diseases | Q38626544 | ||
| Multiresistant Staphylococcus aureus: genetics and evolution of epidemic Australian strains | Q39224551 | ||
| Prevention of respiratory infections by povidone-iodine gargle | Q39290276 | ||
| New strategies for management of oral mucositis in cancer patients | Q40348367 | ||
| The effect of a povidone-iodine mouthwash upon thyroid function and plaque accumulation | Q40517293 | ||
| Effects of chlorine, iodine, and quaternary ammonium compound disinfectants on several exotic disease viruses | Q40626248 | ||
| Respiratory complications of gastroesophageal reflux disease | Q41185411 | ||
| Oral complications of cancer chemotherapy: present status and future studies. | Q41458982 | ||
| Role of povidone iodine in periapical surgeries: Hemostyptic and anti-inflammatory? | Q41488179 | ||
| Prevention of bacterial endocarditis. Recommendations by the American Heart Association | Q41543471 | ||
| Effect of low-concentration povidone iodine on postoperative complications after third molar surgery: a pilot split-mouth study | Q41728633 | ||
| Efficacy of Perimed antibacterial system on established gingivitis. (I). Clinical results | Q42120989 | ||
| Efficacy of 10% Povidone Iodine in children affected with early childhood caries: an in vivo study | Q43005513 | ||
| Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products | Q43177014 | ||
| Use of standardized oral hygiene in the prevention and therapy of mucositis in patients treated with radiochemotherapy of head and neck neoplasms | Q43527608 | ||
| Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus | Q43627876 | ||
| Potentiation of infectivity and pathogenesis of influenza A virus by a house dust mite protease | Q43739201 | ||
| Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients | Q43764077 | ||
| The use of PVP-iodine as an adjunct to non-surgical treatment of chronic periodontitis | Q43784915 | ||
| Incidence of oral complications and application of a preventive protocol in children with acute leukemia | Q43895625 | ||
| Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations | Q43994124 | ||
| Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis | Q43994150 | ||
| Bactericidal activity of topical antiseptics and their gargles against Bordetella pertussis. | Q44395942 | ||
| Reduction of potential respiratory pathogens by oral hygienic treatment in patients undergoing endotracheal anesthesia | Q44539987 | ||
| In vitro evaluation of different chemical agents for the decontamination of gutta-percha cones | Q44542600 | ||
| Effect of povidone-iodine on Streptococcus mutans in children with extensive dental caries. | Q44840772 | ||
| Gargling with povidone-iodine reduces the transport of bacteria during oral intubation | Q45138595 | ||
| Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. | Q45210681 | ||
| The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial | Q46640612 | ||
| Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel) for wound healing in vitro | Q46672736 | ||
| Comparative study of in vitro cytotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel) and selected antiseptics | Q46954513 | ||
| In vitro short-time killing activity of povidone-iodine (Isodine Gargle) in the presence of oral organic matter | Q46954521 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | respiratory tract infection | Q754447 |
| P304 | page(s) | 1247-1256 | |
| P577 | publication date | 2015-08-06 | |
| 2015-11-01 | |||
| P1433 | published in | International Journal of Clinical Practice | Q15758177 |
| P1476 | title | Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections | |
| P478 | volume | 69 |
| Q47122410 | Antibiofilm and Anti-Inflammatory Activities of Houttuynia cordata Decoction for Oral Care. |
| Q52579452 | Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm. |
| Q99731640 | Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic |
| Q49813543 | Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo. |
| Q55111746 | In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. |
| Q36753906 | In Vitro Inhibition of Cytopathic Effect of Influenza Virus and Human Immunodeficiency Virus by Bamboo Leaf Extract Solution and Sodium Copper Chlorophyllin |
| Q104282191 | In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice |
| Q99365663 | Molecular iodine |
| Q41676886 | Povidone-iodine for the management of oral mucositis during cancer therapy. |
| Q90325852 | The efficacy of diluted topical povidone-iodine rinses in the management of recalcitrant chronic rhinosinusitis: a prospective cohort study |
Search more.